NCT05457140Recruiting
Multiomic Diagnostics in Youth With Psychosis
Multiomic Diagnostics in Child and Adolescent Psychosis
Source: ClinicalTrials.gov · Last updated 14 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Rady Children's Institute for Genomic Medicine seeks to understand the genomes and immune systems in 15 children and adolescents who are admitted to Rady Children's Hospital Child and Adolescent Psychiatry Service with psychotic symptoms or schizophrenia. Cutting-edge genome and protein sequencing technology will be used to better understand how immunological and genetic assessments may improve our ability to identify the cause of psychosis and impact care. The investigator also hopes to identify new genetic and/or autoimmune causes of psychosis that may inform new treatment for future patients.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 8 Jul 2022
- Start date
- 10 Oct 2022
- Primary completion date
- Aug 2025
- Lead sponsor
- Rady Pediatric Genomics & Systems Medicine Institute
- Diseases
- Schizophrenia
- NCT number
- NCT05457140
What you commit to
- Study type: Interventional
- Planned participants: 15
- From 10 Oct 2022 to the primary completion date, Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Already received any prior whole genome sequencing or exome sequencing.
Other
- Child/Adolescent patients who do not meet any of the inclusion criteria, or those who:
- Unable to approach the family or patient for enrollment.
- Unable to obtain informed consent.
- Family members are ineligible for participation in this study if:
- They are known to not be genetically related to the child/adolescent patient participant
- They are a member of a protected research population
Who the study is looking for
- Individual in whom one of the following criteria is met:
- Child/adolescent admitted to the Rady Children's CAPS with symptoms of first break psychosis
- OR
- Biological parents of child/adolescent enrolled in this study for the purposes of reflex testing. Family members are eligible for participation in this study if they are presumed genetically related to a patient participant.
Age in the registry: 7 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rady Children's Hospital - San Diego Coordinator of this site? Confirm its status | San Diego | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.